Grading of Soft Tissue Sarcomas: Proposal for a Reproducible, Albeit Limited Scheme

  • P. Meister
Part of the Current Topics in Pathology book series (CT PATHOLOGY, volume 89)


After determination of the histological type a grading has to be carried out according to accepted criteria including cellularity, pleomorphism, mitotic activity and necrosis. The presence of intercellular substances, collagenous or mucoid, ought to be considered as favorable factor judging the degree of differentiation.


Proliferate Cell Nuclear Antigen Soft Tissue Sarcoma Mitotic Activity Soft Tissue Tumor Malignant Fibrous Histiocytoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Altmannsberger M, Alles J, Fitz H, Jundt G, Osborn M (1986) Mesenchymale Tumormarker. Verh Dtsch Ges Pathol 72: 150–163Google Scholar
  2. Appelman H (1986) Smooth muscle tumors of the gastrointestinal tract. Am J Surg Pathol 10 (Suppl 1): 83–99PubMedGoogle Scholar
  3. Baak J (1990) Mitosis counting in tumors. Hum Pathol 21: 683–684PubMedCrossRefGoogle Scholar
  4. Baak J, Oort J (1983) A manual of morphometry in diagnostic pathology. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  5. Bauer H, Kreisberg A, Tribukait B (1991) DNA content prognosis in soft tissue sarcoma. Acta Orthop Scand 62: 187–194PubMedCrossRefGoogle Scholar
  6. Becker R, Venzon D, Lack E et al. (1991) Cytometry and morphometry of malignant fibrous histiocytoma of the extremities. Am J Surg Pathol 15: 957–964PubMedCrossRefGoogle Scholar
  7. Böcking A (1990) DNA-Zytometrie und Automation in der klinischen Diagnostik. Verh Dtsch Ges Pathol 74: 176–185PubMedGoogle Scholar
  8. Böcking A, Adler C, Common H et al. (1984) Algorithm for a DNA cytophotometric diagnosis and grading of malignancy. Anal Quant Cytol 30: 1–8Google Scholar
  9. Broders A, Hargrave R, Meyerding H (1939) Pathological features of soft tissue fibrosarcoma: with special reference to the grading of its malignancy. Surg Gyneco Obstet 69: 267–280Google Scholar
  10. Brooks J (1982) Immunohistochemistry of soft tissue tumors. Hum Pathol 13: 969–974PubMedCrossRefGoogle Scholar
  11. Brooks J (1986) The significance of double phenotypic pattern and markers in human saracomas. Am J Pathol 125: 113–123PubMedGoogle Scholar
  12. Brooks J (1989) Disorders of soft tissue. In: Sternberg S (ed) Diagnostic surgical pathology. Raven, New YorkGoogle Scholar
  13. Brown D, Theaker J, Banks P, Gatter K, Mason D (1987) Cytokeratin expression in smooth muscle tumors. Histopathology 11: 477–486PubMedCrossRefGoogle Scholar
  14. Castro E, Hajdu S, Fortner J (1973) Surgical therapy of fibrosarcoma of extremities: a reappraisal. Arch Surg 107: 284–286PubMedCrossRefGoogle Scholar
  15. Coindre J, de Marscarel A, Trojani M, de Mascarel I, Pages A (1988a) Immunohistohemical study of rhabdomyosarcoma. Unexpected staining with S 100 protein and cytokeratin. J Pathol 155: 127–132PubMedCrossRefGoogle Scholar
  16. Coindre J, Bui N, Bonichon F et al. (1988b) Histopathologic grading in spindle cell soft tissue sarcomas. Cancer 61: 2305–2309PubMedCrossRefGoogle Scholar
  17. Costa J, Wesley R, Glatstein E, Rosenberg S (1984) The grading of soft tissue sarcomas. Cancer 53: 530–541PubMedCrossRefGoogle Scholar
  18. Cross S, Start R, Smith J (1990) Does delay in fixation affect the number of mitotic figures in processed tissue? J Clin Pathol 43: 597–599PubMedCrossRefGoogle Scholar
  19. Dallenbach F (1979) Das sogenannte Leiomyosarkom in situ des Uterus. Verh Dtsch Ges Pathol 63: 633–640Google Scholar
  20. Donhuijsen K (1986) Reproducibility and significance in grading of malignancy. Hum Pathol 17: 1122–1125PubMedCrossRefGoogle Scholar
  21. Donhuijsen K, Budach V, van Beuningen D, Schmidt U (1988) Instability of xenotransplanted soft tissue sarcomas. Cancer 61: 68–75PubMedCrossRefGoogle Scholar
  22. Donhuijsen K, Schmidt U, Hirche H et al. (1990) Changes in mitotic rate and cell cycle fractions caused by delayed fixation. Hum Pathol 21: 709–714PubMedCrossRefGoogle Scholar
  23. Eilber F, Huth J, Mirra J, Rosen G (1990) Progress in the recognition and treatment of soft tissue sarcomas. Cancer 65: 660–666PubMedCrossRefGoogle Scholar
  24. El-Naggar, Garcia G (1992) Epitheloid sarcoma. Flow cytometric study of DNA content and regional DNA heterogeneity. Cancer 69: 1721–1728PubMedCrossRefGoogle Scholar
  25. Enzinger F, Weiss S (1988) Soft tissue tumors, 2nd edn. Mosby, St LouisGoogle Scholar
  26. Enzinger F, Winslow D (1962) Liposarcoma: a study of 103 cases. Virchows Arch 335: 361–388Google Scholar
  27. Erlandson R (1984) Diagnostic immunohistochemistry of human tumors. An interim evaluation. Am J Surg Pathol 8: 615–624PubMedCrossRefGoogle Scholar
  28. Eto H, Toiyam K, Tsuda N, Tagawa Y, Itakura H (1992) Flow cytometric DNA analysis of vascular soft tissue tumors, including African endemic-type Kaposi’s sarcoma. Hum Pathol 23: 1055–1060PubMedCrossRefGoogle Scholar
  29. Evans H (1979) Liposaracoma: a study of 55 cases with reassessment of its classification. Am J Surg Pathol 3: 507–523PubMedCrossRefGoogle Scholar
  30. Evans H, Soule E, Winkelman R (1979) Atypical lipoma, atypical intramuscular lipoma, and well differentiated retroperitoneal liposarcoma. Cancer 43: 574–584PubMedCrossRefGoogle Scholar
  31. Fidler I (1978) Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 38: 2651–2660PubMedGoogle Scholar
  32. Garcia R, Coltrera M, Gown A (1989) Analysis of proliferative grade using anti-PCNA/cyclin monclonal antibodies in fixed, embedded tissues: comparison with flow cytometry analysis. Am J Pathol 134: 733–739PubMedGoogle Scholar
  33. Gerdes J, Becker M, Key G, Cattoretti (1992) Immunhistological detection of tumor growth factor (Ki-67 antigen) in formalinfixed and routinely processed tissue. J Pathol (in press)Google Scholar
  34. Graem N, Helweg-Larsen K (1979) Mitotic activity and delayed fixation of tumor tissue. Acta Pathol Scand [A] 87: 375–378Google Scholar
  35. Haapsalo H, Pesonen E (1989) Volume corrected mitotic index ( M/V-Index ). Pathol Res Pract 185: 551–554Google Scholar
  36. Hajdu S (1979) Pathology of soft tissue tumors. Lea and Febiger, PhiladelphiaGoogle Scholar
  37. Hall P, Levison D, Woods A et al. (1990) Proliferating nuclear antigen (PCNA) immunolocalisation in paraffin sections. J Pathol (in press)Google Scholar
  38. Haukins H, Camacko-Velasquez J (1987) Rhabdomyosarcoma in children. Am J Surg Pathol 11: 531–542CrossRefGoogle Scholar
  39. Hedley O, Friedlander M, Taylor I et al (1983) Methods for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 31: 1333PubMedCrossRefGoogle Scholar
  40. Hedley O, Friedlander M, Taylor I (1985) Application of DNA flow cytometry of paraffin- embedded archival material for the study of aneuploidy and its clinical significance. Cytometry 6: 327–333PubMedCrossRefGoogle Scholar
  41. Hermanek P, Scheibe O, Spiessl B, Wagner G (1987) TNM-Klassifikation maligner Tumoren, 4th edn. Springer, Berlin Heidelberg New YorkGoogle Scholar
  42. Hilsenbeck S, Allred D (1992) Improved method of estimating mitotic activity in solid tumors. Hum Pathol 23: 601–602PubMedCrossRefGoogle Scholar
  43. Iwasaki H, Isayama T, Johzaki K, Kikuchi M (1987) MFH: evidence of perivascular mesenchymal cell origin. Am J Pathol 128: 528–537PubMedGoogle Scholar
  44. Katenkamp D (1988) Cellular heterogeneity. Explanation of changing of tumor phenotype and biologic behaviour in soft tissue sarcomas. Pathol Res Pract 183: 698–705PubMedCrossRefGoogle Scholar
  45. Katenkamp D, Raikhlin (1985) Stem cell concept and heterogeneity of malignant soft tissue tumors. Exp Pathol 28: 3–11PubMedCrossRefGoogle Scholar
  46. Katenkamp D, Stiller D (1990) Weichgewebstumoren. Barth, JenaGoogle Scholar
  47. Key G, Becker M, Baron B et al. (1992) Preparation and immunobiochemical haracterization of Ki-67 equivalent murine antibody (MIB 1-3) generated against recombinant parts of the Ki-67 antigen (to be published)Google Scholar
  48. Killion J, Fidler I (1989) The biology of tumor metastasis. Sem Oncol 16: 106–115Google Scholar
  49. Kiyabu M, Bishop B, Parker J et al. (1988) Smooth muscle tumors of the gastrointestinal tract. Flow cytometric quantitation of DNA and nuclear antigen content and correlation with histologic grade. Am J Surg Pathol 12: 954–960PubMedCrossRefGoogle Scholar
  50. Kreicberg A, Söderberg A, Zetterberg A (1980) The prognostic significance of nuclear DNA-content in chondrosarcoma. Anal Quant Cytol 4: 271Google Scholar
  51. Kreicberg A, Tribukeit B, Willem J et al. (1987) DNA flow analysis in soft tissue tumors. Cancer 59: 128–133CrossRefGoogle Scholar
  52. Landberg G, Tan E, Roos G (1990) Flow cytometric multiparameter analysis of cell nuclear antigen/eyclin and Ki-67 antigen. Exp Cell Res 187: 111–118PubMedCrossRefGoogle Scholar
  53. Mackenzie D (1964) Fibroma: a dangerous diagnosis. Br J Surg 51: 607–612PubMedCrossRefGoogle Scholar
  54. Meister P (1988) Weichgewebssarkome. Klassifizierung oder Graduierung? Zentralbl Allg Pathol Pathol Anat 134: 355–362Google Scholar
  55. Meister P (1992) Weichgewebssarkome. I. Allgemeines. Fortbld Aktuel Krebsdiagn Ther 60 /61: 29–34Google Scholar
  56. Miettinen M, Lehto V, Badley R, Virtanen I (1982) Expression of intermediate filaments in soft-tissue sarcomas. Int J Cancer 30: 541–546PubMedCrossRefGoogle Scholar
  57. Myhre-Jensen O, Kaae O, Madsen E et al. (1983) Histopathological grading in soft tissue tumors. Acta Pathol Scand [A] 91: 145–150Google Scholar
  58. Perrone T, Dehner L (1988) Prognostically favorable “mitotically active” smooth-muscle tumors of the uterus. Am J Surg Pathol 12: 1–8PubMedCrossRefGoogle Scholar
  59. Pritchard D, Soule E, Taylor W, Ivins J (1974) Fibrosaroma. Cancer 33: 888–897PubMedCrossRefGoogle Scholar
  60. Quinn C, Wright N (1990) The clinical assessment of proliferation and growth in human tumors. J Pathol 160: 93–102PubMedCrossRefGoogle Scholar
  61. Rabes H, Meister P (1979) Analysis of proliferative compartments in human tumors. Cancer 44: 799–813PubMedCrossRefGoogle Scholar
  62. Rüssel W, Cohen J, Enzinger F et al. (1977) A clinical pathological staging system for soft tissue sarcomas. Cancer 40: 1562–1570CrossRefGoogle Scholar
  63. Sadler D, Coghill S (1989) Histopathologists, malignancies and undefined high-power fields. Lancet 333: 785–786CrossRefGoogle Scholar
  64. Sapi Z, Bodo M, Sugar J (1989) DNA cytometry of soft tissue tumors with TV image analysis. Pathol Res Pract 185: 363–367PubMedCrossRefGoogle Scholar
  65. Schmidt D, Reimann O, Treuer J, Harms D (1986) Cellular differentiation and prognosis in embryonal rhabdomyosarcoma. Virchows Arch 409: 183–194CrossRefGoogle Scholar
  66. Schutte B, Reynder M, Bosman F et al. (1985) Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded material. Cytometry 6: 26–30PubMedCrossRefGoogle Scholar
  67. Scott S, Reiman H, Pritchard D, Ilstrup DC (1989) Soft tissue fibrosarcoma. Cancer 64: 925–931PubMedCrossRefGoogle Scholar
  68. Silverberg S (1976) Reproducibility of the mitotic count in the histologic diagnosis of smooth muscle tumors of the uterus. Hum Pathol 7: 451–454PubMedCrossRefGoogle Scholar
  69. Silvestrini R, Costa A, Veneroni S et al. (1988) Camparative analysis of different approaches to investigate cell kinetics. Cell Tissue Kinet 21: 123–131PubMedGoogle Scholar
  70. Simpson J, Dutt P, Page D (1992) Expressions of mitoses per thousend cells and cell density in breast carcinoma. Hum Pathol 23: 608–611PubMedCrossRefGoogle Scholar
  71. Stenfert Kroese M, Rutgeres D, Wils I et al. (1990) The relevance of the DNA index and proliferation rate in the grading of benign and malignant soft tissue tumors. Cancer 65: 1782–1788CrossRefGoogle Scholar
  72. Sulser H (1978) Das Rhabdomysarkom. Virchows Arch 379: 35–71Google Scholar
  73. Swanson S, Brook G (1990) Proliferation markers Ki-67 and pl04 in soft tissue lesions. Am J Pathol 137: 1491–1500PubMedGoogle Scholar
  74. Takafumi U, Katsuyuki A, Masahiko T (1989) Prognostic significance of Ki-67 reactivity in soft tissue sarcomas. Cancer 63: 1607CrossRefGoogle Scholar
  75. Tham K (1992) Estimation of mitotic count in tumors. Hum Pathol 23: 1313–1314PubMedCrossRefGoogle Scholar
  76. Van Haelst-Pisani C, Buckner J, Reiman H, Schaid D, Edmonson J, Hahn R (1991) Does histologic grade in soft tissue sarcoma influence response rate to systemic chemotherapy? Cancer 68: 2354–2358PubMedCrossRefGoogle Scholar
  77. Van Unnik J, Coinder J, Contesso G et al. (1987) Grading of soft tissue sarcomas. In: Ryan JR, Baker LO (eds) Recent concepts in sarcoma treatment. Kluwer, UtrechtGoogle Scholar
  78. Waaseem N, Lane D (1990) Monoclonal antibody analysis of the proliferating cell nuclear antigen ( PCNA ). J Cell Sci 90: 121–129Google Scholar
  79. Weiss S (1993) Histological typing of soft tissue tumors, 2nd edn. Springer, Berlin Heidelberg New YorkGoogle Scholar
  80. Weiss S, Bratthauer G, Morris P (1988) Postirradiation malignant fibrous histiocytoma expres-sing cytokeratin. Am J Surg Pathol 12: 554–558PubMedCrossRefGoogle Scholar
  81. Zehrer R, Bauer T, Marks K, Weltevreden A (1990) Ki-67 and grading of malignant fibrous histiocytoma. Cancer 66: 1984–1990CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • P. Meister

There are no affiliations available

Personalised recommendations